Medtronic Acquires Bellco for Undisclosed Amount

Medtronic has acquired privately held Bellco, in a deal the company says will be a foundational component of its recently formed renal care solutions business.

Medtronic acquired Bellco, an Italian company, from Charme Capital Partners, manager of the pan-European Charme Funds. Terms of the deal were not disclosed.

Bellco has created therapies and systems for the treatment of renal failure, multiple organ failure and sepsis. Bellco’s dialyzers and chronic and acute dialysis machines perform dialysis for adult, pediatric and neonatal end stage renal disease patients.

For more than 40 years, Bellco has offered advanced blood purification treatments for ESRD patients with chronic and acute kidney injury. The company’s solutions are available in more than 50 countries. — Jonathon Shacat